ArticleFrontiers in immunology2023

Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues.

Somanath Kallolimath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.